| 08:00 AM - 09:30 AM | PROFFERED PAPERS CLINICAL - 7 min (5+2) (11 ABSTRACTS) |
| Judges | Dr. Raghunadharao Digumarti, Vizag; Dr. Pankaj Panda, Chennai; Dr. S. Anbarasan Sekar, Mumbai; Dr. A.K. Anand, Delhi |
| Topic | STUDY ON EFFECT OF IMMUNOSUPRESSION IN OUTCOME OF PATIENTS WITH CERVICAL CARCINOMA – A SINGLE INSTITUTIONAL STUDY |
| Presenter | Dr. Padma Priya |
| Topic | Radiotherapy Combined with Immune Checkpoint Inhibitors Across Solid Tumors: A Meta-Analysis of 32 Landmark Clinical Trials |
| Presenter | Dr. Muthiah K |
| Topic | When the Sun Meets the Cell: Chronotherapy Insights in Metastatic Renal Cell Carcinoma Patients receiving Immune Checkpoint Inhibitors |
| Presenter | Dr. Abhijith P B |
| Topic | Metastatic Rectal Melanoma- riding on immunotherapy to prolong survival in a deadly disease |
| Presenter | Dr. Anirban Ghosh |
| Topic | Use of perioperative chemoimmunotherapy in a case of second malignancy of urinary bladder following post-transplant multiple myeloma |
| Presenter | Dr. Kishalay Baidya |
| Topic | Integrating Targeted and Immunotherapy in Advanced Hepatocellular Carcinoma: An Analysis of Reported Clinical Outcomes with Lenvatinib-Pembrolizumab Combination |
| Presenter | Dr. Tanishka M |
| Topic | Efficacy of low-dose Nivolumab in advanced cancers: A retrospective analysis from Medical Oncology clinic In Eastern India |
| Presenter | Dr. Priyadip Maiti |
| Topic | Utility of Immune Checkpoint Inhibitors in Brain Tumors Associated with Primary Mismatch Repair Deficiency Syndromes |
| Presenter | Dr. Alec Reginald Errol Correa |
| Topic | CTNNB1 Mutation Predicts for Poor Response to Immunotherapy in Mismatch Repair Deficient Stage IV Colon Cancer: A case report and literature review |
| Presenter | Joel Abraham Mathew |
| Topic | Neoadjuvant Immunotherapy in Advanced Melanoma: First Indian Experience |
| Presenter | Jestin Sabu |
| Topic | IMMUNO-SPARE: ESTABLISHING IMMUNE-SPARING DOSE–VOLUME GUIDELINES IN PELVIC RADIATION THERAPY |
| Presenter | Dr. Padma Priya |
| 09:30 AM - 10:00 AM | Highlight Session: Miracle of Mind for Wellness |
| Session Coordinator | Dr. Ashwin Paul, Kanyakumari; Dr. Muneer Khalam, Kollam; Dr. Barnini Ghosh, Kolkata; Dr. Teena Rajan, Kollam; Dr. Shruti Gohel, Vadodara; Dr. K. Chandralekha, Chennai |
| Speaker | Dr. Suresh Anand, Chennai; Dr. Sujith Kumar Mullapally, Chennai |
| 10:00 AM - 12.00 PM | Session 13: Immuno-Oncology in Hemato-Oncological Cancers-Part 2 |
| Session Coordinator | Dr. Ashwin Paul, Kanyakumari; Dr. Muneer Khalam, Kollam |
| Chairpersons | Dr. Hemant Malhotra, Jaipur; Dr. (Col ) Prakash Chitalkar, Indore; Dr. Navin Khattry, Mumbai; Dr. Chandran Nair, Thalassery |
| 10:00 AM - 10:20 AM | I-OSI KEYNOTE 10 |
| Topic | Immuno-Oncology in Myeloma- How I treat in 2026? |
| Speaker | Dr. Shaji K. Kumar, Rochester, US |
| 10:20 AM - 10:40 AM | Car T cells for Hematological Cancers in 2026 |
| Speaker | Dr. Vikram Mathews, Vellore |
| 10:40 AM - 11:00 AM | Integrative Multi-Omics Approaches in Hemato-Oncological Cancers: From Biological Networks to Theragnostic Biomarkers |
| Speaker | Dr. Srikanth Rapole, Pune |
| 11:00 AM - 11:30 AM | Panel Discussion: Lymphoma Panel |
| Moderator | Dr. Stalin Chowdary Bala, Vizag |
| Panelists | Dr. Shaji K. Kumar, Rochester, US; Dr. Srikanth Rapole, Pune; Dr. Balkrishna Padate, Mumbai; Dr. Deepak George, Chennai; Dr. Ram Abhinav, Coimbatore; Dr. Suresh S, Chennai; Dr. Teena Rajan, Kollam; Dr. Muneer A, Kollam; Dr. Barnini Ghosh, Kolkata |
| 11:30 AM - 12:00 PM | Panel Discussion: Myeloma Panel |
| Moderator | Dr. Nikita Mehra, Guwahati |
| Panelists | Dr. Shaji K. Kumar, Rochester, US; Dr. Vikram Mathews, Vellore; Dr. Srikanth Rapole, Pune; Dr. Varun Raj, Kochi; Dr. Deepan Rajamanickam, Namakkal; Dr. Rahul Bhargava, Delhi; Dr. Chakor Vora, Pune; Dr Shruti Gohel, Vadodara; Dr. Ashvin Jeberson Paul, Vellore; Dr K. Chandralekha, Chennai |
| 12:00 PM - 12:40 PM | Session 14: Symposium on Immuno-Oncology in Clinics: Novel Indications Part 3 |
| Session Coordinator | Dr. Teena Rajan, Kollam; Dr. Barnini Ghosh, Kolkata |
| Chairpersons | Dr. Deepan Rajamanickam, Namakkal; Dr. Srinivas Chilukuri, Chennai; Dr. Anita Ramesh, Chennai |
| 12:00 PM - 12:20 PM | Shaping First line mNSCLC care with Mono-Immunotherapy: Clinical Learnings from IMpower110 & IPSOS study |
| Speaker | Dr. Suresh S, Chennai |
| 12:20 PM - 12:40 PM | SBRT and Immuno-Oncology- How I treat in 2026? |
| Speaker | Dr. A.K. Anand, Delhi |
| 12:40 PM - 01:30 PM | Session 15: Immuno-Oncology in CNS, Pediatric and Rare Cancers |
| Session Coordinator | Dr. Shruti Gohel, Vadodara; Dr. K. Chandralekha, Chennai |
| Chairpersons | Dr. Vishnu Ramanujan, Chennai; Dr. Amit Jain, Meerut; Dr. Hemalatha Doss, Chennai |
| 12:40 PM - 01:00 PM | I-OSI KEYNOTE 11 |
| Topic | Impact of Molecular Oncology in CNS tumors: How I treat in 2026 ? |
| Speaker | Dr. Michael Prados, California, US |
| 01:00 PM - 01:15 PM | Immuno-Oncology in Pediatric Oncology- How I treat in 2026? |
| Speaker | Dr. Venkatraman Radhakrishnan, Chennai |
| 01:15 PM - 01:30 PM | Immuno-Oncology in Melanoma- How I treat in 2026? |
| Speaker | Dr. Ashish Singh, Vellore |
| 01:30 PM - 01:50 PM | HCC: '' CheckMate 9DW: Advancing Hepatocellular Carcinoma (HCC) therapy with Dual IO: Nivolumab+Ipilimumab'' |
| Speaker | Dr. Ram Abhinav, Coimbatore |
| 02:00 PM - 02:15 PM | VALEDICTORY FUNCTION |
| 02:15 PM | LUNCH AND WRAP UP |
